BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254 AND Prognosis
6 results:

  • 1. Nuclear PLD1 combined with npm1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
    Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
    Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion.
    Zhu Q; He P; Zheng C; Chen Z; Qi S; Zhou D; Li Y; Ouyang Q; Zi H; Tang H; Xing J; Xie Y; Zhu S; Ren J; Huang J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8369-8378. PubMed ID: 37079049
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Immortalization-upregulated protein promotes pancreatic cancer progression by regulating npm1/FHL1-mediated cell-cycle-checkpoint protein activity.
    Luo Q; Pan Y; Fu Q; Zhang X; Zhou S; Yu P; Tian H; Liu P; Chen S; Zhang H; Qin T
    Cell Biol Toxicol; 2023 Oct; 39(5):2069-2087. PubMed ID: 35142956
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma.
    Zhao X; Li H; Lyu S; Zhai J; Ji Z; Zhang Z; Zhang X; Liu Z; Wang H; Xu J; Fan H; Kou J; Li L; Lang R; He Q
    Int J Biol Sci; 2021; 17(10):2590-2605. PubMed ID: 34326696
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PRMT1 promotes the tumor suppressor function of p14
    Repenning A; Happel D; Bouchard C; Meixner M; Verel-Yilmaz Y; Raifer H; Holembowski L; Krause E; Kremmer E; Feederle R; Keber CU; Lohoff M; Slater EP; Bartsch DK; Bauer UM
    EMBO J; 2021 Jul; 40(13):e106777. PubMed ID: 33999432
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. npm1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells.
    Zhu Y; Shi M; Chen H; Gu J; Zhang J; Shen B; Deng X; Xie J; Zhan X; Peng C
    Oncotarget; 2015 Aug; 6(25):21443-51. PubMed ID: 26068981
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.